6th Edition of International Conference on Tissue Engineering and Regenerative Medicine
September 28-30 | London, UK
Translational and Clinical Applications
The journey from laboratory innovation to bedside care requires rigorous validation, regulatory clearance, and scalable production. Translational and clinical applications in regenerative medicine emphasize how preclinical successes evolve into clinically viable therapies. It involves refining delivery systems, validating efficacy in human models, and aligning treatments with patient-specific needs. Technologies like 3D-printed grafts, cell-based therapies, and gene-modified tissues are now being tested in controlled trials. Translational and clinical applications also address manufacturing challenges, ethical oversight, and physician training to ensure successful implementation. As more therapies reach early-phase and advanced clinical stages, the path to accessible and reliable regenerative solutions is becoming clearer and more standardized globally.
Kunal Mitra
Florida Tech, United States
Nagy Habib
Imperial College London, United Kingdom
Alexander Seifalian
Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Paige Derr
National Institutes of Health, United States
Aradhana Kasimsetty
National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States
Lisa Martin
University Grenoble Alpes, France
Audrey Cherblanc
Healshape SAS, FranceSubmit your abstract Today
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States